Regulation of Protease-activated Receptor-1 Signaling
Regulation of Protease-activated Receptor-1 Signaling
批准号:
7339647
负责人:
Joann Trejo
金额:
$3.28万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-01-01 至 2008-03-31
关键词:
Adaptor Signaling ProteinArrestinArrestinsBindingBlood PlateletsBlood VesselsCOS-7 CellCardiovascular DiseasesCellsClathrinCoagulantsCouplesCouplingCytoplasmic TailDevelopmentDiffuseDown-RegulationDynaminEmbryoEndopeptidasesEndothelial CellsEventFamilyFibroblastsG-Protein-Coupled ReceptorsGTP-Binding ProteinsGenerationsGoalsHemostatic functionHumanInflammatoryKnock-outLigand BindingLigandsLysosomesMediatingMediator of activation proteinMolecularMusPAR-1 ReceptorPathway interactionsPeptide HydrolasesPhosphorylationPrevention strategyProcessPropertyProteinase-Activated ReceptorsReceptor SignalingRegulationRelative (related person)RoleSignal TransductionSmooth Muscle MyocytesSorting - Cell MovementThrombinThrombosisTyrosineVascular SystemWound Healingatherogenesisbasecell typecoated pitdesensitizationnovelprototypereceptorresponsesorting nexinstrafficking
中文摘要
描述(由申请人提供):本提案的总体目标是了解凝血酶调节信号的机制。凝血酶是一种凝血酶,可引起多种细胞效应,对止血和血栓形成以及血管损伤所产生的炎症和增殖反应是必不可少的。因此,了解凝血酶信号转导机制可能为凝血酶相关心血管疾病的防治提供新的策略。蛋白水解酶激活受体(PARs)是G蛋白偶联受体(GPCRs),介导细胞内大部分凝血酶反应。PAR1是该家族的原型,是人类血小板、内皮细胞、成纤维细胞和平滑肌细胞中凝血酶信号的主要介体。PAR1被不可逆转的蛋白水解性激活,被内化并直接与溶酶体结合。导致PAR1信号终止的机制尚不清楚。Betaarrestins与大多数磷酸化的GPCRs结合,介导脱敏和内化。磷酸化对于终止PAR1信号非常重要(至少对Gq而言)。我们发现,Betaarr1是PAR1解偶联到Gq信号的主要介体。PAR1与GQ、GI和G12/13偶联,PAR1与这些不同的G蛋白亚型解偶联的分子基础尚不清楚。我们将使用来自Betaarrestin基因敲除的小鼠胚胎成纤维细胞(MEF)和COS-7细胞来描述?arrestins在PAR1信号转导中的作用。激活的PAR1的内化和溶酶体分选也是终止受体信号的关键。PAR1是通过依赖于笼蛋白和动力素的途径内化的,该途径不依赖于拦阻蛋白。我们提供了基于酪氨酸的基序和可能是一种新的接头蛋白调节PAR1内化的初步证据。最后,我们的研究证明了SNX1和SNX2在调节PAR1的溶酶体分类中的一个新的作用,并提出了SNXS在GPCR运输中普遍发挥作用的令人兴奋的可能性。这项建议的具体目的是:(1)描述PAR1脱敏的分子基础,(2)定义PAR1新的内化特性,以及(3)确定分类连接蛋白调节激活的PAR1溶酶体降解的分子机制。
英文摘要
DESCRIPTION (provided by applicant): The overall goal of this proposal is to understand the mechanisms of thrombin-regulated signaling. Thrombin, a coagulant protease, elicits a variety of cellular effects that are essential for hemostasis and thrombosis, as well as inflammatory and proliferative responses produced by vascular damage. Therefore, understanding the mechanisms of thrombin signaling may provide new strategies for the prevention and treatment of thrombin-related cardiovascular diseases. Protease-activated receptors (PARs) are G protein-coupled receptors (GPCRs) that mediate most of thrombin responses in cells. PAR1, the prototype of this family, is the predominant mediator of thrombin signaling in human platelets, as well as in endothelial cells, fibroblasts and smooth muscle cells. PAR1 is irreversibly proteolytically activated, intemalized and sorted directly to lysosomes. The mechanisms that contribute to termination of PAR1 signaling are not clearly understood. Betaarrestins bind to most phosphorylated GPCRs to mediate desensitization and internalization. Phosphorylation is important for termination of PAR1 signaling (at least to Gq). We found that Betaarr1 is the predominant mediator of PAR1 uncoupling to Gq signaling. PAR1 couples to Gq, Gi, and G12/13, and the molecular basis of PAR1 uncoupling to these distinct G protein subtypes is not known. We will use mouse embryonic fibroblasts (MEFs) derived from betaarrestin knockouts and COS-7 cells to delineate the role of ?arrestins in PAR1 signaling. Internalization and lysosomal sorting of activated PAR1 are also critical for termination of receptor signaling. PAR1 is internalized via a clathrin- and dynamin-dependent pathway that is independent of arrestins. We provide initial evidence that a tyrosine-based motif and perhaps a novel adaptor protein regulate internalization of PAR1. Finally, our studies demonstrate a novel role for SNX1 and perhaps SNX2 in regulating lysosomal sorting of PAR1 and raise the exciting possibility that SNXs function generally in GPCR trafficking. The specific aims of this proposal are to: (1) delineate the molecular basis of PAR1 desensitization, (2) define the novel internalization properties of PAR1, and (3) define the molecular mechanisms by which sorting nexins regulate lysosomal degradation of activated PAR1.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Endothelial Cytoprotective Signaling by Activated Protein C/Protease-activated Receptor-1
-
批准号:10816153
-
项目类别:
-
资助金额:$4.98万
-
财政年份:2023
-
负责人:Joann Trejo
-
依托单位:
Endothelial Cytoprotective Signaling by Activated Protein C/Protease-activated Receptor-1
-
批准号:10594367
-
项目类别:
-
资助金额:$60.47万
-
财政年份:2023
-
负责人:Joann Trejo
-
依托单位:
UC San Diego FIRST Program
-
批准号:10494788
-
项目类别:
-
资助金额:$15.8万
-
财政年份:2022
-
负责人:Joann Trejo
-
依托单位:
UC San Diego FIRST Program
-
批准号:10701795
-
项目类别:
-
资助金额:$473.21万
-
财政年份:2022
-
负责人:Joann Trejo
-
依托单位:
Cell Signaling by Protease-activated G Protein-coupled Receptors
-
批准号:10371096
-
项目类别:
-
资助金额:$46.5万
-
财政年份:2018
-
负责人:Joann Trejo
-
依托单位:
Cell signaling by G protein-coupled receptors
-
批准号:10623554
-
项目类别:
-
资助金额:$53.09万
-
财政年份:2018
-
负责人:Joann Trejo
-
依托单位:
Cell Signaling by Protease-activated G Protein-coupled Receptors
-
批准号:9486492
-
项目类别:
-
资助金额:$34.1万
-
财政年份:2018
-
负责人:Joann Trejo
-
依托单位:
Cell Signaling by Protease-activated G Protein-coupled Receptors
-
批准号:9891860
-
项目类别:
-
资助金额:$46.5万
-
财政年份:2018
-
负责人:Joann Trejo
-
依托单位:
Cell Signaling by Protease-activated G Protein-coupled Receptors
-
批准号:9919120
-
项目类别:
-
资助金额:$2.92万
-
财政年份:2018
-
负责人:Joann Trejo
-
依托单位:
2013 Molecular Pharmacology Gordon Research Conference and Gordon Research Semina
-
批准号:8520657
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2013
-
负责人:Joann Trejo
-
依托单位:
Mechanisms Regulating GPCR Trafficking
-
批准号:8209041
-
项目类别:
-
资助金额:$32.5万
-
财政年份:2010
-
负责人:Joann Trejo
-
依托单位:
Mechanisms Regulating GPCR Trafficking
-
批准号:8652182
-
项目类别:
-
资助金额:$32.94万
-
财政年份:2010
-
负责人:Joann Trejo
-
依托单位:
Mechanisms Regulating GPCR Trafficking
-
批准号:8400892
-
项目类别:
-
资助金额:$31.37万
-
财政年份:2010
-
负责人:Joann Trejo
-
依托单位:
Mechanisms Regulating GPCR Trafficking
-
批准号:8907624
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2010
-
负责人:Joann Trejo
-
依托单位:
Mechanisms Regulating GPCR Trafficking
-
批准号:8792621
-
项目类别:
-
资助金额:$32.94万
-
财政年份:2010
-
负责人:Joann Trejo
-
依托单位:
Mechanisms Regulating GPCR Trafficking
-
批准号:8006389
-
项目类别:
-
资助金额:$32.5万
-
财政年份:2010
-
负责人:Joann Trejo
-
依托单位:
Mechanisms Regulating GPCR Trafficking
-
批准号:7807578
-
项目类别:
-
资助金额:$32.83万
-
财政年份:2010
-
负责人:Joann Trejo
-
依托单位:
Mechanisms Regulating GPCR Trafficking
-
批准号:8073721
-
项目类别:
-
资助金额:$9.58万
-
财政年份:2010
-
负责人:Joann Trejo
-
依托单位:
Regulation of Protease-activated Receptor-1 Signaling
-
批准号:6839936
-
项目类别:
-
资助金额:$40.52万
-
财政年份:2004
-
负责人:Joann Trejo
-
依托单位:
Regulation of Protease-activated Receptor-1 Signaling
-
批准号:8207979
-
项目类别:
-
资助金额:$44.74万
-
财政年份:2004
-
负责人:Joann Trejo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
坡模酸通过抑制β-arrestin2介导的M2型巨噬细胞极化抗肝纤维化的机制研究
-
批准号:2026JJ81069
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:朱萱
-
依托单位:
CB2R/β-arrestin1通路调控星形胶质细胞内质网—线粒体互作在术后谵妄的作用及机制
-
批准号:82571377
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:华福洲
-
依托单位:
β-Arrestin动态结构与激活机制的核磁共振研究
-
批准号:32571402
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2025
-
负责人:胡蕴菲
-
依托单位:
小胶质细胞ADRB2/β-arrestin2通路缺陷导致Aβ吞噬障碍促进阿尔茨海默病认知损伤的机制研究
-
批准号:82571630
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:柴高尚
-
依托单位:
中华绒螯蟹β-arrestin1通过Hippo/Yki信号通路调节循环血淋巴细胞数量稳态的机制研究
-
批准号:32503239
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:李豪
-
依托单位:
电针刺激ST36通过DRD1/β-arrestin1信
号通路抑制炎症性骨丢失的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:刘冠峤
-
依托单位:
电针激活β-arrestin 1/IFN通路促进“冷-热”免疫表型转化协同IDO抑制剂治疗MSS肠癌的机制研究
-
批准号:
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:时佳琪
-
依托单位:
清肺理痰方通过SCFAs/GPR43/β-arrestin2信号轴调控炎症反应改善细菌感染COPD急性加重的机制研究
-
批准号:82405053
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2024
-
负责人:丁奇
-
依托单位:
基于β2-AR/β-arrestin2通路探讨电针调控交感神经抑制子宫内膜B细胞分化治疗慢性子宫内膜炎的机制
-
批准号:82405569
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2024
-
负责人:席瑾
-
依托单位:
槲皮素联合人参皂苷Rg1靶向β-Arrestin/InR/BubR1协同促进生殖干细胞再生缓解卵巢储备功能减退的机制研究
-
批准号:82404993
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2024
-
负责人:付宝玉
-
依托单位: